A the latest update from the Shift-OUT study molnupiravir showed a relative threat reduction of 30% for hospitalization or Loss of life, along with the relative hazard reduction death was 89%, when molnupiravir when compared to placebo. To aid the approval of a new medication for use in Japan, it https://ashleyr998dpz1.blogsvirals.com/profile